2024-11-19 08:30:11
PharmAbcine to participate at BIO-Europe 2020
Corporate/ 2023-07-23
PharmAbcine to participate at BIO-Europe...

DAEJEON,South Korea,Oct. 23,2020-- PharmAbcine Inc. (KOSDAQ: 208340ks) announced today that the company will participate in the 26thAnnual I...

Reistone Biopharma Announces Positive Topline Results from Phase 2 Clinical Trial Evaluating SHR0302, a JAK1 Inhibitor for the Treatment of Moderate-to-Severe Atopic Dermatitis
Health/ 2023-07-22
Reistone Biopharma Announces Positive To...

SHR0302 monotherapy achieved positive results on reaching primary endpoints with statistical significance,delivering significant improvement...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release